COVID‐19 has spread swiftly throughout the world posing a global health emergency. The
significant numbers of deaths attributed to this pandemic have researchers battling to …

Since early 2020, the entire world has been facing a disastrous outbreak of the SARS-CoV-2
virus, with massive reporting of death and infections per day. Medical practitioners adopted …

Background Mucosal antibodies play a critical role in preventing SARS-CoV-2 infections or
reinfections by blocking the interaction of the receptor-binding domain (RBD) with the …

The causative factor of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is continuously mutating. Interestingly, identified mutations mainly occur in the spike …

In the coming months, most American adults will have the opportunity to receive at least one
of up to five different COVID-19 vaccines produced by Operation Warp Speed and released …

Background Patients with chronic lymphocytic leukemia (CLL) have reduced seroconversion
rates and lower binding antibody (Ab) and neutralizing antibody (NAb) titers than healthy …

Introduction The development of a yeast-expressed recombinant protein-based vaccine
technology co-developed with LMIC vaccine producers and suitable as a COVID-19 vaccine …

The understanding of the molecular mechanisms driving the fitness of the SARS-CoV-2 virus
and its mutational evolution is still a critical issue. We built a simplified computational model …

Signaling pathway alterations in COVID-19 of living humans as well as therapeutic targets of
the host proteins are not clear. We analyzed 317 urine proteomes, including 86 COVID-19 …

The new coronavirus began to spread around the world in late 2019. Initially, it was found
only in China, but in the following days there were reported cases of infections in other …